Bonini, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 1.530
AS - Asia 1.214
EU - Europa 891
SA - Sud America 372
AF - Africa 52
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.065
Nazione #
US - Stati Uniti d'America 1.472
SG - Singapore 558
BR - Brasile 311
IT - Italia 255
CN - Cina 204
VN - Vietnam 195
SE - Svezia 146
FR - Francia 108
IE - Irlanda 64
DE - Germania 62
ID - Indonesia 51
RU - Federazione Russa 49
FI - Finlandia 47
GB - Regno Unito 43
HK - Hong Kong 39
BD - Bangladesh 31
NL - Olanda 27
AR - Argentina 24
JP - Giappone 24
IN - India 23
MX - Messico 22
IQ - Iraq 18
CA - Canada 17
AT - Austria 16
ZA - Sudafrica 16
PL - Polonia 13
BE - Belgio 10
EC - Ecuador 10
ES - Italia 9
MA - Marocco 9
SA - Arabia Saudita 9
TR - Turchia 9
UA - Ucraina 9
KR - Corea 7
VE - Venezuela 7
IR - Iran 6
RS - Serbia 6
AZ - Azerbaigian 5
CL - Cile 5
CO - Colombia 5
JM - Giamaica 5
PK - Pakistan 5
PY - Paraguay 5
AO - Angola 4
DZ - Algeria 4
EG - Egitto 4
HN - Honduras 4
JO - Giordania 4
NP - Nepal 4
PH - Filippine 4
TN - Tunisia 4
UZ - Uzbekistan 4
AU - Australia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
LT - Lituania 3
RO - Romania 3
AM - Armenia 2
CH - Svizzera 2
DM - Dominica 2
ET - Etiopia 2
HR - Croazia 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
PE - Perù 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
GA - Gabon 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PW - Palau 1
TW - Taiwan 1
TZ - Tanzania 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.065
Città #
Chandler 300
Singapore 273
San Jose 215
Ashburn 128
Ho Chi Minh City 65
Dublin 63
Beijing 56
New York 48
Hanoi 46
Jakarta 43
Milan 43
Lauterbourg 42
Marseille 36
Boston 35
Helsinki 35
Princeton 35
Hong Kong 31
Rome 27
São Paulo 27
Dearborn 26
Wilmington 26
Los Angeles 24
Moscow 23
Tokyo 23
San Mateo 21
Boardman 17
Council Bluffs 16
Nanjing 16
Da Nang 15
Dallas 15
Hefei 15
Rio de Janeiro 14
Nuremberg 12
Johannesburg 11
Paris 11
Ann Arbor 10
Brussels 10
Frankfurt am Main 10
London 10
Redwood City 10
Belo Horizonte 9
Bremen 9
Chicago 9
Lappeenranta 9
Santa Clara 9
Brooklyn 8
Buffalo 8
Fairfield 8
Orem 8
St Louis 8
Warsaw 8
Changsha 7
Dhaka 7
Hebei 7
Shanghai 7
The Dalles 7
Toronto 7
Woodbridge 7
Atlanta 6
Bergamo 6
Florence 6
Haiphong 6
Hải Dương 6
Manaus 6
Memphis 6
Munich 6
Norwalk 6
Seoul 6
Amsterdam 5
Auburn Hills 5
Baku 5
Belgrade 5
Biên Hòa 5
Brasília 5
Cambridge 5
Curitiba 5
Houston 5
Jiaxing 5
Mexico City 5
Redmond 5
Vienna 5
Amman 4
Baghdad 4
Bexley 4
Düsseldorf 4
Jeddah 4
Kent 4
Luanda 4
Mountain View 4
Nanchang 4
Naples 4
Ninh Bình 4
Perugia 4
Piracicaba 4
Quito 4
Riyadh 4
Salvador 4
Sorocaba 4
Stockholm 4
São José do Rio Preto 4
Totale 2.226
Nome #
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)—a EAACI position paper 223
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment 184
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 177
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 141
Severe asthma: One disease and multiple definitions 131
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 121
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 111
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact 110
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma 109
Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry 107
The Impact of Telemedicine during Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic and Future Perspectives: A Systematic Review 103
Exercise-Induced Bronchoconstriction: Background, Prevalence, and Sport Considerations 100
Asthma, allergy and the olympics: A 12-year survey in elite athletes 99
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study 97
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial 97
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 96
Anti-muscarinic drugs as preventive treatment of exercise-induced bronchoconstriction (EIB) in children and adults 96
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018 95
Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma 94
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 93
Research highlights from the 2018 European Respiratory Society International Congress: airway disease 93
Allergy screening in a schoolchildren-based population 93
Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis 92
The role of mobile apps in allergic respiratory diseases: An italian multicentre survey report 91
Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure 90
Small Airways Disease as a Novel Target for Mepolizumab in Asthma—The SASAM Prospective Real-Life Study 87
Minimal clinically important difference for asthma endpoints: An expert consensus report 87
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paper 84
Let research leave you breathless, not physical exercise! 83
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 80
Feasibility of the Allergy Questionnaire for Athletes (AQUA © ) in pediatric age 78
Electronic health (e-Health): Emerging role in asthma 76
The role of the small airways in the pathophysiology of asthma and chronic obstructive pulmonary disease 74
Correlation between intrarenal arterial stiffness and exercise tolerance in systemic sclerosis patients without renal and cardiopulmonary impairment: The role of the microvascular damage 70
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers 70
European Respiratory Society guidelines for the diagnosis of asthma in adults 70
Eucapnic Voluntary Hyperpnea: Gold Standard for Diagnosing Exercise-Induced Bronchoconstriction in Athletes? 69
Biosimilars and drug development in allergic and immunologic diseases 69
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 67
Real-world experience with benralizumab in patients with severe eosinophilic asthma: A case series 64
Mucins MUC5B and MUC5AC in distal airways and honeycomb spaces: Comparison among idiopathic pulmonary fibrosis/usual interstitial pneumonia, fibrotic nonspecific interstitial pneumonitis, and control lungs 60
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy 56
Exertional dyspnoea in interstitial lung diseases: The clinical utility of cardiopulmonary exercise testing 47
Totale 4.134
Categoria #
all - tutte 20.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022242 4 2 5 15 9 1 3 31 15 31 36 90
2022/2023714 92 105 79 99 33 78 39 49 96 9 27 8
2023/2024340 12 90 5 53 9 31 17 11 3 24 39 46
2024/2025667 26 20 64 22 27 34 22 21 103 67 135 126
2025/20261.911 264 44 131 260 271 92 333 78 147 169 88 34
Totale 4.134